[Clinical progression of the first wave of novel coronavirus infection in Ostrava].

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: TRIOS Country of Publication: Czech Republic NLM ID: 101189112 Publication Model: Print Cited Medium: Print ISSN: 1211-264X (Print) Linking ISSN: 1211264X NLM ISO Abbreviation: Klin Mikrobiol Infekc Lek Subsets: MEDLINE
    • Publication Information:
      Original Publication: Praha : TRIOS
    • Subject Terms:
      COVID-19/*epidemiology; Adenosine Monophosphate/analogs & derivatives ; Adenosine Monophosphate/therapeutic use ; Aged ; Alanine/analogs & derivatives ; Alanine/therapeutic use ; Amides/therapeutic use ; COVID-19/mortality ; COVID-19/physiopathology ; Czech Republic ; Female ; Humans ; Hydroxychloroquine/therapeutic use ; Length of Stay ; Male ; Pyrazines/therapeutic use ; Respiration, Artificial
    • Abstract:
      Objectives: The first case of coronavirus infection in the Moravian-Silesian Region was diagnosed on March 12, 2020. The study aimed to describe the first wave and clinical manifestation of the coronavirus epidemic at the Department of Infectious Diseases in Ostrava.
      Material and Methods: The sample comprised a total of 195 patients requiring hospitalization at the Department of Infectious Diseases in Ostrava between March 1 and August 31, 2020. The virus was diagnosed using polymerase chain reaction from nasopharyngeal swabs in 192 patients and from the bronchoalveolar lavage in one patient. In the other two patients, serological tests were applied using virus neutralization assays and ELISA specific antibodies.
      Results: The sample included 100 men and 95 women. The mean age was 69.5 years. The most common diagnosis was pneumonia, observed in 123 patients (63 %). Respiratory symptoms without pneumonia were seen in 37 patients (19 %); loss of smell and taste in 14 patients (7 %); cardiovascular complications in 9 patients (5 %); acute psychosis in 2 patients (1 %); and diarrhea and vomiting in 25 patients (13 %). The remaining 23 patients (12 %) did not present any symptoms. The mean length of hospital stay was 11 days. The most frequent comorbidity was cardiovascular disease (70 %). A total of 39 patients died (20 %); their mean age was 77 years. Mechanical ventilation was started in 16 patients, of whom 7 died (43 %). The treatment was mostly symptomatic. Hydroxychloroquine was administered to 21 patients (11 %), favipiravir to 26 patients (13 %) and remdesivir to 13 patients (6 %).
      Conclusion: Respiratory complications predominated in the majority of patients with coronavirus infection. In most cases, the treatment was symptomatic. One-fifth of the patients, mostly elderly ones, died.
    • Accession Number:
      0 (Amides)
      0 (Pyrazines)
      3QKI37EEHE (remdesivir)
      415SHH325A (Adenosine Monophosphate)
      4QWG6N8QKH (Hydroxychloroquine)
      EW5GL2X7E0 (favipiravir)
      OF5P57N2ZX (Alanine)
    • Publication Date:
      Date Created: 20210108 Date Completed: 20210113 Latest Revision: 20210113
    • Publication Date:
      20231215
    • Accession Number:
      33418595